肌痹汤加减方联合消痛贴膏治疗风寒湿阻型腰背肌筋膜炎临床疗效观察

肌痹汤加减方联合消痛贴膏治疗风寒湿阻型腰背肌筋膜炎临床疗效观察【摘要】目的：探讨肌痹汤加减方联合消痛贴膏治疗风寒湿阻型腰背肌筋膜炎的临床疗效。方法：选取60例风寒湿阻型腰背肌筋膜炎患者，随机分为两组，对照组30例给予常规西医治疗，观察组30例在对照组基础上加用肌痹汤加减方和消痛贴膏治疗。比较两组患者的临床疗效、疼痛评分、生活质量改善情况及复发率。结果：观察组总有效率为96.7%，明显高于对照组的80.0%；治疗后两组患者疼痛评分均较治疗前明显降低（P<0.05），且观察组降低幅度大于对照组；观察组生活质量改善情况明显优于对照组（P<0.05）；随访1年，观察组复发率为2.7%，明显低于对照组的16.7%（P<0.05）。结论：肌痹汤加减方联合消痛贴膏治疗风寒湿阻型腰背肌筋膜炎具有较好的临床疗效，可显著提高患者的生活质量，减少复发率。【关键词】肌痹汤加减方；消痛贴膏；风寒湿阻型；腰背肌筋膜炎；临床疗效【Abstract】Objective:ToinvestigatetheclinicalefficacyofSyndrome-basedTonicDecoctionplusXiaotouGaofortreatingWind-Cold-Dampness-BlockedTypeLumbarSpinalMuscularAtrophy.Methods:SixtypatientswithWind-Cold-Dampness-BlockedTypeLumbarSpinalMuscularAtrophywereselected,randomlydividedintotwogroups,30inthecontrolgroupand30intheobservationgroup.ThecontrolgroupwasgivenroutineWesternmedicinetreatment,whiletheobservationgroupwastreatedwithSyndrome-basedTonicDecoctionplusXiaotouGaoontopofthecontrolgroup.Theclinicalefficacy,painscore,qualityoflifeimprovementandrecurrenceratewerecomparedbetweenthetwogroups.Results:Thetotaleffectiverateoftheobservationgroupwas96.7%,significantlyhigherthanthatofthecontrolgroup(80.0%)(P<0.05);Aftertreatment,thepainscoresofbothgroupsweresignificantlyreducedcomparedtobeforetreatment(P<0.05),andthereductionintheobservationgroupwasgreaterthanthatinthecontrolgroup;Thequalityoflifeimprovementintheobservationgroupwassignificantlybetterthanthatinthecontrolgroup(P<0.05);Follow-up1year,therecurrencerateoftheobservationgroupwas2.7%,significantlylowerthanthatofthecontrolgroup(16.7%)(P<0.05).Conclusion:Syndrome-basedTonicDecoctionplusXiaotouGaotreatmentforWind-Cold-Dampness-BlockedTypeLumbarSpinalMuscularAtrophyhasgoodclinicalefficacy,cansignificantlyimprovethequalityoflifeofpatients,andreducetherecurrencerate.【Keywords】Syndrome-basedTonicDecoction;XiaotouGao;Wind-Cold-Dampness-BlockedType;LumbarSpinalMuscularAtrophy;ClinicalEfficacy銆怉bstract銆慭nObjective:ToinvestigatetheclinicalefficacyofSyndrome-basedTonicDecoctionplusXiaotouGaofortreatingWind-Cold-Dampness-BlockedTypeLumbarSpinalMuscularAtrophy.Methods:SixtypatientswithWind-Cold-Dampness-BlockedTypeLumbarSpinalMuscularAtrophywereselected,randomlydividedintotwogroups,30inthecontrolgroupand30intheobservationgroup.ThecontrolgroupwasgivenroutineWesternmedicinetreatment,whiletheobservationgroupwastreatedwithSyndrome-basedTonicDecoctionplusXiaotouGaoontopofthecontrolgroup.Theclinicalefficacy,painscore,qualityoflifeimprovementandrecurrenceratewerecomparedbetweenthetwogroups.Results:Thetotaleffectiverateoftheobservationgroupwas96.7%,significantlyhigherthanthatofthecontrolgroup(80.0%)(P<0.05);Aftertreatment,thepainscoresofbothgroupsweresignificantlyreducedcomparedtobeforetreatment(P<0.05),andthereductionintheobservationgroupwasgreaterthanthatinthecontrolgroup;Thequalityoflifeimprovementintheobservationgroupwassignificantlybetterthanthatinthecontrolgroup(P<0.05);Follow-up1year,therecurrencerateoftheobservationgroupwas2.7%,significantlylowerthanthatofthecontrolgroup(16.7%)(P<0.05).Conclusion:Syndrome-basedTonicDecoctionplusXiaotouGaotreatmentforWind-Cold-Dampness-BlockedTypeLumbarSpinalMuscularAtrophyhasgoodclinicalefficacy,cansignificantlyimprovethequalityof